BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meier RPH, Longchamp A, Mohiuddin M, Manuel O, Vrakas G, Maluf DG, Buhler LH, Muller YD, Pascual M. Recent progress and remaining hurdles toward clinical xenotransplantation. Xenotransplantation 2021;28:e12681. [PMID: 33759229 DOI: 10.1111/xen.12681] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
Number Citing Articles
1 Groth T, Stegmayr BG, Ash SR, Kuchinka J, Wieringa FP, Fissell WH, Roy S. Wearable and implantable artificial kidney devices for end-stage kidney disease treatment-Current status and review. Artif Organs 2022. [PMID: 36129158 DOI: 10.1111/aor.14396] [Reference Citation Analysis]
2 Sun S, Lu D, Zhong H, Li C, Yang N, Huang B, Ni S, Li X. Donors for nerve transplantation in craniofacial soft tissue injuries. Front Bioeng Biotechnol 2022;10:978980. [DOI: 10.3389/fbioe.2022.978980] [Reference Citation Analysis]
3 Carrier AN, Verma A, Mohiuddin M, Pascual M, Muller YD, Longchamp A, Bhati C, Buhler LH, Maluf DG, Meier RPH. Xenotransplantation: A New Era. Front Immunol 2022;13:900594. [PMID: 35757701 DOI: 10.3389/fimmu.2022.900594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lee H, Park EM, Ko N, Choi K, Oh KB, Kang HJ. Effect of Factor H on Complement Alternative Pathway Activation in Human Serum Remains on Porcine Cells Lacking N-Glycolylneuraminic Acid. Front Immunol 2022;13:859261. [PMID: 35444661 DOI: 10.3389/fimmu.2022.859261] [Reference Citation Analysis]
5 Feng H, Li T, Du J, Xia Q, Wang L, Chen S, Zhu L, Pan D, Wang Y, Chen G. Both Natural and Induced Anti-Sda Antibodies Play Important Roles in GTKO Pig-to-Rhesus Monkey Xenotransplantation. Front Immunol 2022;13:849711. [PMID: 35422817 DOI: 10.3389/fimmu.2022.849711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yerly P, Rotman S, Regamey J, Aubert V, Aur S, Kirsch M, Hullin R, Pascual M. Complement blockade with eculizumab to treat acute symptomatic humoral rejection after heart transplantation. Xenotransplantation 2022;:e12726. [PMID: 35001433 DOI: 10.1111/xen.12726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Cozzi E, Schneeberger S, Bellini MI, Berglund E, Böhmig G, Fowler K, Hoogduijn M, Jochmans I, Marckmann G, Marson L, Neuberger J, Oberbauer R, Pierson RN 3rd, Reichart B, Scobie L, White C, Naesens M; for ESOT Workstream 1 of the TLJ (Transplantation Learning Journey) Project. Organ transplants of the future: planning for innovations including xenotransplantation. Transpl Int 2021. [PMID: 34459040 DOI: 10.1111/tri.14031] [Cited by in F6Publishing: 3] [Reference Citation Analysis]